I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| epithelial cell | 3 studies | 27% ± 4% | |
| fibroblast | 3 studies | 27% ± 11% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| epithelial cell | 3 studies | 27% ± 4% | |
| fibroblast | 3 studies | 27% ± 11% |
Insufficient scRNA-seq data for expression of TBL2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| breast | 100% | 1770.31 | 459 / 459 | 100% | 34.79 | 1118 / 1118 |
| esophagus | 100% | 1431.51 | 1445 / 1445 | 100% | 22.65 | 183 / 183 |
| lung | 100% | 1667.31 | 578 / 578 | 100% | 31.48 | 1155 / 1155 |
| ovary | 100% | 2182.97 | 180 / 180 | 100% | 27.63 | 430 / 430 |
| pancreas | 100% | 2315.34 | 328 / 328 | 100% | 26.04 | 178 / 178 |
| prostate | 100% | 2152.84 | 245 / 245 | 100% | 41.80 | 502 / 502 |
| stomach | 100% | 1467.15 | 359 / 359 | 100% | 29.89 | 286 / 286 |
| intestine | 100% | 1634.04 | 966 / 966 | 100% | 35.08 | 526 / 527 |
| skin | 100% | 2381.46 | 1809 / 1809 | 100% | 37.97 | 471 / 472 |
| uterus | 100% | 2123.08 | 170 / 170 | 100% | 24.41 | 458 / 459 |
| bladder | 100% | 1713.57 | 21 / 21 | 100% | 29.65 | 502 / 504 |
| kidney | 100% | 1278.61 | 89 / 89 | 99% | 22.74 | 896 / 901 |
| thymus | 100% | 2117.36 | 653 / 653 | 99% | 26.13 | 601 / 605 |
| liver | 100% | 1181.03 | 226 / 226 | 99% | 17.06 | 403 / 406 |
| adrenal gland | 100% | 2630.15 | 258 / 258 | 98% | 21.78 | 226 / 230 |
| brain | 97% | 865.28 | 2569 / 2642 | 100% | 23.24 | 704 / 705 |
| adipose | 100% | 1768.05 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 17.18 | 29 / 29 |
| spleen | 100% | 1509.67 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 19.02 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 25.29 | 1 / 1 |
| blood vessel | 100% | 1452.57 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 99% | 24.83 | 79 / 80 |
| heart | 97% | 836.71 | 831 / 861 | 0% | 0 | 0 / 0 |
| muscle | 94% | 654.43 | 758 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 91% | 1099.19 | 843 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0030968 | Biological process | endoplasmic reticulum unfolded protein response |
| GO_0042149 | Biological process | cellular response to glucose starvation |
| GO_0071456 | Biological process | cellular response to hypoxia |
| GO_0005783 | Cellular component | endoplasmic reticulum |
| GO_0005789 | Cellular component | endoplasmic reticulum membrane |
| GO_0031369 | Molecular function | translation initiation factor binding |
| GO_0019901 | Molecular function | protein kinase binding |
| GO_0051219 | Molecular function | phosphoprotein binding |
| GO_0003723 | Molecular function | RNA binding |
| Gene name | TBL2 |
| Protein name | Transducin-like 2 isoform 1 Transducin-like 2 isoform 3 Transducin beta like 2 Transducin beta-like protein 2 (WS beta-transducin repeats protein) (WS-betaTRP) (Williams-Beuren syndrome chromosomal region 13 protein) TBL2 protein |
| Synonyms | UNQ563/PRO1125 WBSCR13 |
| Description | |
| Accessions | ENST00000450285.5 ENST00000458466.1 F8WDI9 ENST00000417008.5 ENST00000452125.5 F8WCC7 F2Z3G3 ENST00000435792.5 A0A0S2Z5C1 F8WEC3 E9PF19 F8WCR3 ENST00000424598.5 F8WBP2 ENST00000426966.5 ENST00000433464.5 A0A087WXC6 ENST00000432538.5 ENST00000437521.5 F8WBD9 ENST00000305632.11 F8WB62 ENST00000479892.5 Q9Y4P3 Q96E41 A0A0S2Z5F3 |
